Projet ETERNITY (Horizon Europe, appel à projets 2021)
Action : Doctoral Networks
Panel : Life Sciences
Statut du projet : SIGNED

The worldwide population is ageing and putting our healthcare systems under pressure to cope with age-related diseases. In Europe, there is a need for innovation, knowledge and experts who can prompt significant changes to improve prevention and innovative interventional strategies to counteract altered metabolism in brain during ageing and related disorders. The priority is to ensure brain health throughout life and during ageing. Increased collaboration between academia and private sector is the required milieu to overcome this challenge. The “FuEl ThE bRaiN In healtThY aging and agE-relateD diseases” ETERNITY will contribute to the strengthening of the European innovation capacity by training a new generation of researchers with experience and full understanding of the requirements of academia, pharmaceutical and food supplement companies, and the society. ETERNITY research programme will focus on brain metabolism as a highly promising yet under-explored area. Given the complementary expertise, ETERNITY will have excellent opportunities to delineate different pathways underlying impaired brain metabolism to identify novel pharmaceutical targets and/or nutritional interventional strategies to counteract ageing and related disorders. The early-stage researchers (DCs) will be trained in this environment and provided with a mind-set of future commercial and clinical utilization of their research findings. Apart from the innovative and collaborative approach of the research programme, the DCs will also be provided with a training programme where cutting-edge methodology, innovation and transferable skills are key components. The trained DCs will have excellent intersectoral and interdisciplinary career opportunities and will, together with the ETERNITY partners, provide a solid ground to tackle one of the major societal challenges of our century: finding therapies to promote brain healthy ageing and delay the onset of neurodegenerative diseases.

Mots clés : energy metabolism, brain, animals models, cellular models, obesity, neurodegenarion, ageing

Participants :
- Avencell europe gmbh (Allemagne) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- German Center for Neurodegenerative Diseases (Allemagne) — Partner, beneficiary, Recherche, subvention : 709245.6 €
- Université de Milan (Italie) — Coordinator, beneficiary, Enseignement supérieur ou secondaire, subvention : 778312.8 €
- Sofinol sa (Suisse) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Hôpital universitaire de la Charité de Berlin (Allemagne) — Partner, associated partner, Enseignement supérieur ou secondaire, subvention : 0.0 €
- European Brain Council (Belgique) — Partner, associated partner, Autres, subvention : 0.0 €
- Gesellschaft zur förderung der lebenswissenschaften heidelberg gmbh (Allemagne) — Partner, associated partner, Autres, subvention : 0.0 €
- University Hospital Bonn (Allemagne) — Partner, associated partner, Enseignement supérieur ou secondaire, subvention : 0.0 €
- The visual agency srl (Italie) — Partner, associated partner, Autres, subvention : 0.0 €
- Université de Bordeaux (France) — Partner, associated partner, Enseignement supérieur ou secondaire, subvention : 0.0 €
- CF consulting Finanziamenti Unione Europea (Italie) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Université de Salamanque (Espagne) — Partner, beneficiary, Enseignement supérieur ou secondaire, subvention : 503942.4 €
- Institut national de la santé et de la recherche médicale (France) — Partner, beneficiary, Recherche, subvention : 565387.2 €